Monovalent Antivenom market size is estimated to be worth US$ 907 million in 2022 and is forecast to a readjusted size of US$ 1532 million by 2028 with a CAGR of 8% during the review period. Snake antivenom is a medication made up of antibodies used to treat snake bites by venomous snakes. If the […]
